Literature DB >> 12885434

Tumor necrosis factor alpha increases cytosolic calcium responses to AMPA and KCl in primary cultures of rat hippocampal neurons.

Alok De1, James M Krueger, Steven M Simasko.   

Abstract

Acute behavioral effects of tumor necrosis factor alpha (TNFalpha) have been previously reported, however the cellular basis for these actions are unknown. To address this issue we examined the effects of TNFalpha on AMPA- and depolarization-induced changes in cytosolic Ca(2+) in cultured hippocampal neurons. Single cell Ca(2+) levels were determined with the fluorescent calcium indicator fura-2. TNFalpha caused an up-regulation of AMPA (10 microM)- and depolarization (55 mM KCl)-induced Ca(2+) responses. This effect occurred within a window of concentrations (1 and 10 ng/ml but not 0.1 or 100 ng/ml) and times (3 and 6 h but not 1 and 24 h). The effect was dependent upon protein synthesis (blocked by cycloheximide) and was prevented by the soluble TNF receptor and by a soluble TNF receptor fragment. Treatment with the soluble TNF receptor fragment also caused a decrease in the basal response. The TNFalpha treatment protocols did not appear to produce any toxicity to the neurons. Results are consistent with the hypothesis that TNFalpha regulates proteins known to be involved in neuronal communication (AMPA receptors) and cell regulation (voltage-dependent calcium channels) in a relatively rapid period of time (a few hours). These actions may be related to the behavioral effects produced by TNFalpha that occur within this time frame.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12885434     DOI: 10.1016/s0006-8993(03)02997-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  33 in total

Review 1.  Catestatin: a multifunctional peptide from chromogranin A.

Authors:  Sushil K Mahata; Manjula Mahata; Maple M Fung; Daniel T O'Connor
Journal:  Regul Pept       Date:  2010-01-28

Review 2.  Local sleep.

Authors:  James M Krueger; Joseph T Nguyen; Cheryl J Dykstra-Aiello; Ping Taishi
Journal:  Sleep Med Rev       Date:  2018-11-12       Impact factor: 11.609

3.  Norman Cousins Lecture. Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids.

Authors:  Linda R Watkins; Mark R Hutchinson; Annemarie Ledeboer; Julie Wieseler-Frank; Erin D Milligan; Steven F Maier
Journal:  Brain Behav Immun       Date:  2006-12-18       Impact factor: 7.217

Review 4.  Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.

Authors:  Mark R Hutchinson; Yehuda Shavit; Peter M Grace; Kenner C Rice; Steven F Maier; Linda R Watkins
Journal:  Pharmacol Rev       Date:  2011-07-13       Impact factor: 25.468

Review 5.  "Listening" and "talking" to neurons: implications of immune activation for pain control and increasing the efficacy of opioids.

Authors:  Linda R Watkins; Mark R Hutchinson; Erin D Milligan; Steven F Maier
Journal:  Brain Res Rev       Date:  2007-07-13

6.  SLEEP AND CYTOKINES.

Authors:  James M Krueger; David M Rector; Lynn Churchill
Journal:  Sleep Med Clin       Date:  2007

Review 7.  Mode of action of cytokines on nociceptive neurons.

Authors:  Nurcan Uçeyler; Maria Schäfers; Claudia Sommer
Journal:  Exp Brain Res       Date:  2009-03-17       Impact factor: 1.972

8.  Depolarization alters phenotype, maintains plasticity of predifferentiated mesenchymal stem cells.

Authors:  Sarah Sundelacruz; Michael Levin; David L Kaplan
Journal:  Tissue Eng Part A       Date:  2013-06-05       Impact factor: 3.845

Review 9.  Sleep as a fundamental property of neuronal assemblies.

Authors:  James M Krueger; David M Rector; Sandip Roy; Hans P A Van Dongen; Gregory Belenky; Jaak Panksepp
Journal:  Nat Rev Neurosci       Date:  2008-11-05       Impact factor: 34.870

10.  Reelin secreted by GABAergic neurons regulates glutamate receptor homeostasis.

Authors:  Cecilia Gonzalez Campo; Mélanie Sinagra; Danièle Verrier; Olivier J Manzoni; Pascale Chavis
Journal:  PLoS One       Date:  2009-05-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.